Mood & Mental Health

·

Review

Psilocybin Trials Promising but Not Very Diverse

Psilocybin Trials Promising but Not Very Diverse

Psilocybin mushrooms

What they found

A review found up to 71% response rates in depression trials, but samples are small and often about 90% white.

A review found up to 71% response rates in depression trials, but samples are small and often about 90% white.

The number

up to 71% response rates and 54% remission at 4 weeks

How solid is it?

Review

Review

Narrative review

Narrative review

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Published in

Brain Sciences

Brain Sciences

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Beyond Clinical Trials

Beyond Clinical Trials

Psilocybin shows strong effects across depression, anxiety, and addiction, with up to 71% response rates and 54% remission at 4 weeks in major depression trials. However, most studies rely on small, highly selective samples (often ~90% white participants) and struggle with placebo control, limiting real-world accuracy.

Psilocybin shows strong effects across depression, anxiety, and addiction, with up to 71% response rates and 54% remission at 4 weeks in major depression trials. However, most studies rely on small, highly selective samples (often ~90% white participants) and struggle with placebo control, limiting real-world accuracy.

Chemo Boost, Skin Repair, and Termite-Grown Mushrooms

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.